Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating risks and management strategies in heart failure patients

Official title: Risk Evaluation and Management in Heart Failure

Run by Ruijin Hospital · NCT02998788 · Data updated 2026-11-12

This study looks at how different lifestyle choices and health conditions affect the long-term health of heart failure patients in China over five years.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment1000 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJune 2016
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedDecember 20, 2016
Trial IDNCT02998788 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and above who are hospitalized with specific heart failure conditions and have impaired cardiac function.

Probably not a fit

Patients with severe co-morbidities that significantly reduce life expectancy or those who refuse to participate will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on a population of heart failure patients in China to investigate how various cardiovascular disease risk factors, including lifestyle behaviors, biomarkers, and intermediate diseases, affect heart failure prognosis. The study aims to enroll 1,000 participants who will be followed for at least 5 years to assess the impact of these factors on health outcomes such as all-cause mortality and cardiovascular events. Data will be collected through direct contact with participants, medical records, and vital statistics. The study will utilize the Cox proportional hazard model to analyze the risk factors associated with health outcomes in heart failure patients.

Why it matters

Potential benefit: If successful, this study could lead to improved management and health outcomes for heart failure patients through targeted interventions based on identified risk factors.

How similar studies have gone: Other studies have shown success in evaluating risk factors in heart failure, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* aged 18 and above
* inpatient with one of the following clinical situations:

  * congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema)
  * cardiogenic shock
  * Insufficient high output cardiac
* with impaired cardiac function diagnosed by echocardiography
* able to provide informed consent

Exclusion Criteria:

* expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months

Where it's running

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.